{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:43:04Z","timestamp":1771011784574,"version":"3.50.1"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2003,5,1]]},"DOI":"10.1038\/sj.gt.3302016","type":"journal-article","created":{"date-parts":[[2003,5,6]],"date-time":"2003-05-06T11:49:51Z","timestamp":1052221791000},"page":"861-874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Immunopathology and the gene therapy of lupus"],"prefix":"10.1038","volume":"10","author":[{"given":"R A","family":"Mageed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G J","family":"Prud'homme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,5,6]]},"reference":[{"key":"BF3302016_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0025-6196(12)60294-8","volume":"60","author":"CJ Michet Jr","year":"1985","unstructured":"Michet Jr CJ et al. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985; 60: 105\u2013113.","journal-title":"Mayo Clin Proc"},{"key":"BF3302016_CR2","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/art.1780210413","volume":"21","author":"AT Masi","year":"1978","unstructured":"Masi AT, Kaslow RA . Sex effects in systemic lupus erythematosus: a clue to pathogenesis. Arthritis Rheum 1978; 21: 480\u2013484.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR4","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1084\/jem.147.6.1568","volume":"147","author":"JR Roubinian","year":"1978","unstructured":"Roubinian JR et al. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB\/NZW F1 mice. J Exp Med 1978; 147: 1568\u20131583.","journal-title":"J Exp Med"},{"key":"BF3302016_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/art.1780250727","volume":"25","author":"T Pincus","year":"1982","unstructured":"Pincus T . Studies regarding a possible function for viruses in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 847\u2013856.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR6","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/art.1780360713","volume":"36","author":"KL Hardgrave","year":"1993","unstructured":"Hardgrave KL, Neas BR, Scofield RH, Harley JB . Antibodies to vesicular stomatitis virus proteins in patients with systemic lupus erythematosus and in normal subjects. Arthritis Rheum 1993; 36: 962\u2013970.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0889-857X(21)00226-X","volume":"20","author":"RL Yung","year":"1994","unstructured":"Yung RL, Richardson BC . Drug-induced lupus. Rheum Dis Clin North Am 1994; 20: 61\u201386.","journal-title":"Rheum Dis Clin North Am"},{"key":"BF3302016_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/art.1780350310","volume":"35","author":"D Deapen","year":"1992","unstructured":"Deapen D et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311\u2013318.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"BF3302016_CR9","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1186\/ar586","volume":"4","author":"MJ Walport","year":"2002","unstructured":"Walport MJ . Complement and systemic lupus erythematosus. Arthritis Res 2002; 4 (Suppl 3): S279\u2013S293.","journal-title":"Arthritis Res"},{"key":"BF3302016_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nri702","volume":"2","author":"JJ O'Shea","year":"2002","unstructured":"O'Shea JJ, Ma A, Lipsky P . Cytokines and autoimmunity. Nat Rev Immunol 2002; 2: 37\u201345.","journal-title":"Nat Rev Immunol"},{"key":"BF3302016_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/sj.gene.6363700","volume":"1","author":"N Tsuchiya","year":"2000","unstructured":"Tsuchiya N et al. New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus. Genes Immun 2000; 1: 501\u2013503.","journal-title":"Genes Immun"},{"key":"BF3302016_CR12","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/1529-0131(199906)42:6<1298::AID-ANR31>3.0.CO;2-F","volume":"42","author":"S Kanemitsu","year":"1999","unstructured":"Kanemitsu S et al. Association of interleukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1298\u20131300.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0014-5793(99)00701-2","volume":"453","author":"H Nakashima","year":"1999","unstructured":"Nakashima H et al. The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus. FEBS Lett 1999; 453: 187\u2013190.","journal-title":"FEBS Lett"},{"key":"BF3302016_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/096120339500400603","volume":"4","author":"PH Schur","year":"1995","unstructured":"Schur PH . Genetics of systemic lupus erythematosus. Lupus 1995; 4: 425\u2013437.","journal-title":"Lupus"},{"key":"BF3302016_CR15","first-page":"275","volume":"246","author":"N Ibnou-Zekri","year":"1999","unstructured":"Ibnou-Zekri N et al. MHC-linked control of murine SLE. Curr Top Microbiol Immunol 1999; 246: 275\u2013280.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BF3302016_CR16","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1172\/JCI114930","volume":"86","author":"JG Tebib","year":"1990","unstructured":"Tebib JG, Alcocer-Varela J, Alarcon-Segovia D, Schur PH . Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus. J Clin Invest 1990; 86: 1961\u20131967.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1172\/JCI114430","volume":"85","author":"MB Frank","year":"1990","unstructured":"Frank MB, McArthur R, Harley JB, Fujisaku A . Anti-Ro(SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients. J Clin Invest 1990; 85: 33\u201339.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1172\/JCI115277","volume":"88","author":"T Olee","year":"1991","unstructured":"Olee T et al. Molecular basis of an autoantibody-associated restriction fragment length polymorphism that confers susceptibility to autoimmune diseases. J Clin Invest 1991; 88: 193\u2013203.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1172\/JCI118552","volume":"97","author":"JE Salmon","year":"1996","unstructured":"Salmon JE et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97: 1348\u20131354.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/1529-0131(200102)44:2<361::AID-ANR54>3.0.CO;2-G","volume":"44","author":"R Zuniga","year":"2001","unstructured":"Zuniga R et al. Low-binding alleles of Fcgamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients. Arthritis Rheum 2001; 44: 361\u2013367.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.gene.6363639","volume":"1","author":"Y Hatta","year":"1999","unstructured":"Hatta Y et al. Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun 1999; 1: 53\u201360.","journal-title":"Genes Immun"},{"key":"BF3302016_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0167-5699(98)01395-4","volume":"20","author":"GC Tsokos","year":"1999","unstructured":"Tsokos GC, Liossis SN . Immune cell signaling defects in lupus: activation, anergy and death. Immunol Today 1999; 20: 119\u2013124.","journal-title":"Immunol Today"},{"key":"BF3302016_CR23","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1172\/JCI1457","volume":"101","author":"SN Liossis","year":"1998","unstructured":"Liossis SN, Ding XZ, Dennis GJ, Tsokos GC . Altered pattern of TCR\/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest 1998; 101: 1448\u20131457.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR24","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/0092-8674(93)90369-2","volume":"73","author":"LD Shultz","year":"1993","unstructured":"Shultz LD et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993; 73: 1445\u20131454.","journal-title":"Cell"},{"key":"BF3302016_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/clin.1996.0170","volume":"81","author":"LE DesJardin","year":"1996","unstructured":"DesJardin LE, Butfiloski EJ, Sobel ES, Schiffenbauer J . Hyperproliferation of BXSB B cells is linked to the Yaa allele. Clin Immunol Immunopathol 1996; 81: 145\u2013152.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF3302016_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/356314a0","volume":"356","author":"R Watanabe-Fukunaga","year":"1992","unstructured":"Watanabe-Fukunaga R et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314\u2013317.","journal-title":"Nature"},{"key":"BF3302016_CR27","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","volume":"76","author":"T Takahashi","year":"1994","unstructured":"Takahashi T et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969\u2013976.","journal-title":"Cell"},{"key":"BF3302016_CR28","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1172\/JCI118643","volume":"97","author":"A Desai-Mehta","year":"1996","unstructured":"Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK . Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996; 97: 2063\u20132073.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR29","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.4049\/jimmunol.165.7.4095","volume":"165","author":"H Lettesjo","year":"2000","unstructured":"Lettesjo H, Burd GP, Mageed RA . CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB \u00d7 NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity. J Immunol 2000; 165: 4095\u20134104.","journal-title":"J Immunol"},{"key":"BF3302016_CR30","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.4049\/jimmunol.165.6.2987","volume":"165","author":"C Mary","year":"2000","unstructured":"Mary C et al. Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice. J Immunol 2000; 165: 2987\u20132996.","journal-title":"J Immunol"},{"key":"BF3302016_CR31","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/intimm\/11.10.1685","volume":"11","author":"Y Jiang","year":"1999","unstructured":"Jiang Y et al. Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int Immunol 1999; 11: 1685\u20131691.","journal-title":"Int Immunol"},{"key":"BF3302016_CR32","first-page":"2537","volume":"29","author":"CY Ho","year":"2002","unstructured":"Ho CY et al. Expression of cyclin B1 and cyclin dependent kinase inhibitor p21 in lymphocytes in patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 2537\u20132544.","journal-title":"J Rheumatol"},{"key":"BF3302016_CR33","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.4049\/jimmunol.167.7.4067","volume":"167","author":"ML Santiago-Raber","year":"2001","unstructured":"Santiago-Raber ML et al. Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J Immunol 2001; 167: 4067\u20134074.","journal-title":"J Immunol"},{"key":"BF3302016_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/91070","volume":"28","author":"K Yasutomo","year":"2001","unstructured":"Yasutomo K et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001; 28: 313\u2013314.","journal-title":"Nat Genet"},{"key":"BF3302016_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/75963","volume":"25","author":"MJ Walport","year":"2000","unstructured":"Walport MJ . Lupus, DNase and defective disposal of cellular debris. Nat Genet 2000; 25: 135\u2013136.","journal-title":"Nat Genet"},{"key":"BF3302016_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1074-7613(01)00201-1","volume":"15","author":"EK Wakeland","year":"2001","unstructured":"Wakeland EK, Liu K, Graham RR, Behrens TW . Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001; 15: 397\u2013408.","journal-title":"Immunity"},{"key":"BF3302016_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/096120339700600708","volume":"6","author":"SH Lee","year":"1997","unstructured":"Lee SH et al. Decreased tumour necrosis factor-beta production in TNFB*2 homozygote: an important predisposing factor of lupus nephritis in Koreans. Lupus 1997; 6: 603\u2013609.","journal-title":"Lupus"},{"key":"BF3302016_CR38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/331356a0","volume":"331","author":"CO Jacob","year":"1988","unstructured":"Jacob CO, McDevitt HO . Tumour necrosis factor-\u03b1 in murine autoimmune \u2018lupus\u2019 nephritis. Nature 1988; 331: 356\u2013358.","journal-title":"Nature"},{"key":"BF3302016_CR39","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1084\/jem.181.3.839","volume":"181","author":"L Llorente","year":"1995","unstructured":"Llorente L et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181: 839\u2013844.","journal-title":"J Exp Med"},{"key":"BF3302016_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1525-1381.1999.99244.x","volume":"111","author":"AN Theofilopoulos","year":"1999","unstructured":"Theofilopoulos AN, Kono DH . The genes of systemic autoimmunity. Proc Assoc Am Physicians 1999; 111: 228\u2013240.","journal-title":"Proc Assoc Am Physicians"},{"key":"BF3302016_CR41","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.4049\/jimmunol.160.8.3805","volume":"160","author":"H Fukuyama","year":"1998","unstructured":"Fukuyama H et al. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice. J Immunol 1998; 160: 3805\u20133811.","journal-title":"J Immunol"},{"key":"BF3302016_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/1529-0131(200001)43:1<135::AID-ANR17>3.0.CO;2-Q","volume":"43","author":"T Kojima","year":"2000","unstructured":"Kojima T et al. Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus. Arthritis Rheum 2000; 43: 135\u2013139.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR43","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1002\/1521-4141(200007)30:7<2038::AID-IMMU2038>3.0.CO;2-K","volume":"30","author":"D Kontoyiannis","year":"2000","unstructured":"Kontoyiannis D, Kollias G . Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur J Immunol 2000; 30: 2038\u20132047.","journal-title":"Eur J Immunol"},{"key":"BF3302016_CR44","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.156.8.2661","volume":"156","author":"T Zhou","year":"1996","unstructured":"Zhou T et al. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J Immunol 1996; 156: 2661\u20132665.","journal-title":"J Immunol"},{"key":"BF3302016_CR45","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1172\/JCI112882","volume":"79","author":"C Morimoto","year":"1987","unstructured":"Morimoto C et al. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 1987; 79: 762\u2013768.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR46","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.4049\/jimmunol.152.7.3685","volume":"152","author":"W Emlen","year":"1994","unstructured":"Emlen W, Niebur J, Kadera R . Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152: 3685\u20133692.","journal-title":"J Immunol"},{"key":"BF3302016_CR47","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/art.1780231108","volume":"23","author":"M Goto","year":"1980","unstructured":"Goto M, Tanimoto K, Horiuchi Y . Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody. Arthritis Rheum 1980; 23: 1274\u20131281.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR48","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/art.1780330823","volume":"33","author":"M Linker-Israeli","year":"1990","unstructured":"Linker-Israeli M, Quismorio Jr FP, Horwitz DA . CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. Arthritis Rheum 1990; 33: 1216\u20131225.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR49","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.160.5.2539","volume":"160","author":"K Ohtsuka","year":"1998","unstructured":"Ohtsuka K et al. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. J Immunol 1998; 160: 2539\u20132545.","journal-title":"J Immunol"},{"key":"BF3302016_CR50","doi-asserted-by":"publisher","first-page":"7020","DOI":"10.1073\/pnas.87.18.7020","volume":"87","author":"S Rajagopalan","year":"1990","unstructured":"Rajagopalan S, Zordan T, Tsokos GC, Datta SK . Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8-T helper cell lines that express the gamma delta T-cell antigen receptor. Proc Natl Acad Sci USA 1990; 87: 7020\u20137024.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302016_CR51","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/art.1780400508","volume":"40","author":"DA Horwitz","year":"1997","unstructured":"Horwitz DA et al. Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interaction. Arthritis Rheum 1997; 40: 822\u2013833.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR52","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.4049\/jimmunol.160.5.2248","volume":"160","author":"JD Gray","year":"1998","unstructured":"Gray JD, Hirokawa M, Ohtsuka K, Horwitz DA . Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3. J Immunol 1998; 160: 2248\u20132254.","journal-title":"J Immunol"},{"key":"BF3302016_CR53","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/art.1780340411","volume":"34","author":"IL Stekman","year":"1991","unstructured":"Stekman IL et al. Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus. Arthritis Rheum 1991; 34: 459\u2013467.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/BF00918016","volume":"9","author":"S Sierakowski","year":"1989","unstructured":"Sierakowski S, Kucharz EJ, Lightfoot RW, Goodwin JS . Impaired T-cell activation in patients with systemic lupus erythematosus. J Clin Immunol 1989; 9: 469\u2013476.","journal-title":"J Clin Immunol"},{"key":"BF3302016_CR55","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.4049\/jimmunol.163.3.1682","volume":"163","author":"HK Wong","year":"1999","unstructured":"Wong HK, Kammer GM, Dennis G, Tsokos GC . Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J Immunol 1999; 163: 1682\u20131689.","journal-title":"J Immunol"},{"key":"BF3302016_CR56","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1073\/pnas.87.5.1978","volume":"87","author":"P Hasler","year":"1990","unstructured":"Hasler P, Schultz LA, Kammer GM . Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87: 1978\u20131982.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302016_CR57","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.4049\/jimmunol.166.6.4216","volume":"166","author":"EE Solomou","year":"2001","unstructured":"Solomou EE et al. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J Immunol 2001; 166: 4216\u20134222.","journal-title":"J Immunol"},{"key":"BF3302016_CR58","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.4049\/jimmunol.165.11.6627","volume":"165","author":"Y Yi","year":"2000","unstructured":"Yi Y, McNerney M, Datta SK . Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J Immunol 2000; 165: 6627\u20136634.","journal-title":"J Immunol"},{"key":"BF3302016_CR59","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1191\/096120399678847489","volume":"8","author":"K Ohtsuka","year":"1999","unstructured":"Ohtsuka K, Gray JD, Stimmler MM, Horwitz DA . The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity. Lupus 1999; 8: 90\u201394.","journal-title":"Lupus"},{"key":"BF3302016_CR60","first-page":"270","volume":"18","author":"PC Dau","year":"1991","unstructured":"Dau PC, Callahan J, Parker R, Golbus J . Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus. J Rheumatol 1991; 18: 270\u2013276.","journal-title":"J Rheumatol"},{"key":"BF3302016_CR61","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1002\/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2","volume":"43","author":"L Llorente","year":"2000","unstructured":"Llorente L et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 1790\u20131800.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR62","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0140-6736(00)02627-1","volume":"356","author":"AE Traynor","year":"2000","unstructured":"Traynor AE et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 2000; 356: 701\u2013707.","journal-title":"Lancet"},{"key":"BF3302016_CR63","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1172\/JCI109388","volume":"63","author":"AB Gottlieb","year":"1979","unstructured":"Gottlieb AB, Lahita RG, Chiorazzi N, Kunkel HG . Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest 1979; 63: 885\u2013892.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR64","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/1521-4141(200104)31:4<1221::AID-IMMU1221>3.0.CO;2-P","volume":"31","author":"G Mostoslavsky","year":"2001","unstructured":"Mostoslavsky G et al. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 2001; 31: 1221\u20131227.","journal-title":"Eur J Immunol"},{"key":"BF3302016_CR65","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/1357-4310(96)81799-0","volume":"2","author":"S Malkiel","year":"1996","unstructured":"Malkiel S, Kuan AP, Diamond B . Autoimmunity in heart disease: mechanisms and genetic susceptibility. Mol Med Today 1996; 2: 336\u2013342.","journal-title":"Mol Med Today"},{"key":"BF3302016_CR66","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/1529-0131(199908)42:8<1655::AID-ANR14>3.0.CO;2-B","volume":"42","author":"N Hirose","year":"1999","unstructured":"Hirose N et al. A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1655\u20131661.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR67","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1084\/jem.184.3.853","volume":"184","author":"L Reininger","year":"1996","unstructured":"Reininger L et al. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB \u00d7 NZW) F1 mice. J Exp Med 1996; 184: 853\u2013856.","journal-title":"J Exp Med"},{"key":"BF3302016_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/clin.1997.4353","volume":"83","author":"D Folzenlogen","year":"1997","unstructured":"Folzenlogen D et al. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol 1997; 83: 199\u2013204.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF3302016_CR69","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/j.1460-2075.1994.tb06387.x","volume":"13","author":"M Takata","year":"1994","unstructured":"Takata M et al. Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J 1994; 13: 1341\u20131349.","journal-title":"EMBO J"},{"key":"BF3302016_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/clin.1998.4552","volume":"88","author":"M Tolnay","year":"1998","unstructured":"Tolnay M, Tsokos GC . Complement receptor 2 in the regulation of the immune response. Clin Immunol Immunopathol 1998; 88: 123\u2013132.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF3302016_CR71","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1126\/science.7716523","volume":"268","author":"D D'Ambrosio","year":"1995","unstructured":"D'Ambrosio D et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science 1995; 268: 293\u2013297.","journal-title":"Science"},{"key":"BF3302016_CR72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2310\/6650.2001.34042","volume":"49","author":"SN Liossis","year":"2001","unstructured":"Liossis SN et al. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J Invest Med 2001; 49: 157\u2013165.","journal-title":"J Invest Med"},{"key":"BF3302016_CR73","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0950-3579(98)80026-5","volume":"12","author":"LJ Mason","year":"1998","unstructured":"Mason LJ, Isenberg DA . Immunopathogenesis of SLE. Baillieres Clin Rheumatol 1998; 12: 385\u2013403.","journal-title":"Baillieres Clin Rheumatol"},{"key":"BF3302016_CR74","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.4049\/jimmunol.127.6.2483","volume":"127","author":"MJ Dauphinee","year":"1981","unstructured":"Dauphinee MJ, Kipper SB, Wofsy D, Talal N . Interleukin 2 deficiency is a common feature of autoimmune mice. J Immunol 1981; 127: 2483\u20132487.","journal-title":"J Immunol"},{"key":"BF3302016_CR75","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1172\/JCI110579","volume":"69","author":"J Alcocer-Varela","year":"1982","unstructured":"Alcocer-Varela J, Alarcon-Segovia D . Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 1982; 69: 1388\u20131392.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR76","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/0090-1229(91)90065-I","volume":"60","author":"Y Tada","year":"1991","unstructured":"Tada Y et al. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1991; 60: 220\u2013231.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF3302016_CR77","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0165-2478(89)90156-9","volume":"23","author":"NC Phi","year":"1989","unstructured":"Phi NC et al. Cyclic AMP level of lymphocytes in patients with systemic lupus erythematosus and its relation to disease activity. Immunol Lett 1989; 23: 61\u201364.","journal-title":"Immunol Lett"},{"key":"BF3302016_CR78","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/1529-0131(199907)42:7<1458::AID-ANR20>3.0.CO;2-P","volume":"42","author":"GM Kammer","year":"1999","unstructured":"Kammer GM . High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1458\u20131465.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR79","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/anr.1780320507","volume":"32","author":"T Tanaka","year":"1989","unstructured":"Tanaka T et al. Decreased expression of interleukin-2 binding molecules (p70\/75) in T cells from patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 552\u2013559.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR80","first-page":"297","volume":"5","author":"HE Liang","year":"1998","unstructured":"Liang HE et al. Atypical signaling defects prevent IL-2 gene expression in lpr\/lpr CD4-CD8- cells. J Biomed Sci 1998; 5: 297\u2013304.","journal-title":"J Biomed Sci"},{"key":"BF3302016_CR81","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/eji.1830270813","volume":"27","author":"H Sabzevari","year":"1997","unstructured":"Sabzevari H, Propp S, Kono DH, Theofilopoulos AN . G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated\/memory phenotype CD4+ cells of older lupus mice. Eur J Immunol 1997; 27: 1901\u20131910.","journal-title":"Eur J Immunol"},{"key":"BF3302016_CR82","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/346271a0","volume":"346","author":"JC Gutierrez-Ramos","year":"1990","unstructured":"Gutierrez-Ramos JC et al. Recovery from autoimmunity of MRL\/lpr mice after infection with an interleukin-2\/vaccinia recombinant virus. Nature 1990; 346: 271\u2013274.","journal-title":"Nature"},{"key":"BF3302016_CR83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4049\/jimmunol.140.1.59","volume":"140","author":"VE Kelley","year":"1988","unstructured":"Kelley VE et al. Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis. J Immunol 1988; 140: 59\u201361.","journal-title":"J Immunol"},{"key":"BF3302016_CR84","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0161-5890(95)00024-9","volume":"32","author":"GJ Prud'homme","year":"1995","unstructured":"Prud'homme GJ, Kono DH, Theofilopoulos AN . Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice. Mol Immunol 1995; 32: 495\u2013503.","journal-title":"Mol Immunol"},{"key":"BF3302016_CR85","first-page":"1621","volume":"18","author":"WB Graninger","year":"1991","unstructured":"Graninger WB et al. Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis. J Rheumatol 1991; 18: 1621\u20131622.","journal-title":"J Rheumatol"},{"key":"BF3302016_CR86","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/BF00920636","volume":"13","author":"M al-Janadi","year":"1993","unstructured":"al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S . Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13: 58\u201367.","journal-title":"J Clin Immunol"},{"key":"BF3302016_CR87","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1084\/jem.166.3.798","volume":"166","author":"CO Jacob","year":"1987","unstructured":"Jacob CO, van der Meide PH, McDevitt HO . In vivo treatment of (NZB \u00d7 NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med 1987; 166: 798\u2013803.","journal-title":"J Exp Med"},{"key":"BF3302016_CR88","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/eji.1830250103","volume":"25","author":"L Ozmen","year":"1995","unstructured":"Ozmen L et al. Experimental therapy of systemic lupus erythematosus: the treatment of NZB\/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis. Eur J Immunol 1995; 25: 6\u201312.","journal-title":"Eur J Immunol"},{"key":"BF3302016_CR89","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1365-2249.1999.00862.x","volume":"116","author":"Y Tokano","year":"1999","unstructured":"Tokano Y et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)-relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 1999; 116: 169\u2013173.","journal-title":"Clin Exp Immunol"},{"key":"BF3302016_CR90","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S","volume":"41","author":"DA Horwitz","year":"1998","unstructured":"Horwitz DA et al. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 1998; 41: 838\u2013844.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR91","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.4049\/jimmunol.161.12.6878","volume":"161","author":"DG Alleva","year":"1998","unstructured":"Alleva DG, Kaser SB, Beller DI . Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL\/++ and New Zealand Black\/White F1 lupus-prone mice and the Leishmania major-susceptible BALB\/c strain. J Immunol 1998; 161: 6878\u20136884.","journal-title":"J Immunol"},{"key":"BF3302016_CR92","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1084\/jem.183.4.1447","volume":"183","author":"FP Huang","year":"1996","unstructured":"Huang FP et al. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRLMP-lprlpr mice. J Exp Med 1996; 183: 1447\u20131459.","journal-title":"J Exp Med"},{"key":"BF3302016_CR93","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2249.1997.d01-1009.x","volume":"108","author":"FA Houssiau","year":"1997","unstructured":"Houssiau FA et al. IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC). Clin Exp Immunol 1997; 108: 375\u2013380.","journal-title":"Clin Exp Immunol"},{"key":"BF3302016_CR94","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s100670050045","volume":"18","author":"EM Davas","year":"1999","unstructured":"Davas EM et al. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 1999; 18: 17\u201322.","journal-title":"Clin Rheumatol"},{"key":"BF3302016_CR95","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF00270982","volume":"8","author":"AJ Swaak","year":"1989","unstructured":"Swaak AJ, van Rooyen A, Aarden LA . Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus. Rheumatol Int 1989; 8: 263\u2013268.","journal-title":"Rheumatol Int"},{"key":"BF3302016_CR96","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0090-1229(05)80001-7","volume":"61","author":"G Kroemer","year":"1991","unstructured":"Kroemer G, Martinez C . Cytokines and autoimmune disease. Clin Immunol Immunopathol 1991; 61: 275\u2013295.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF3302016_CR97","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","volume":"179","author":"LA Casciola-Rosen","year":"1994","unstructured":"Casciola-Rosen LA, Anhalt G, Rosen A . Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317\u20131330.","journal-title":"J Exp Med"},{"key":"BF3302016_CR98","first-page":"31","volume":"77","author":"A Kitani","year":"1989","unstructured":"Kitani A et al. Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus. Clin Exp Immunol 1989; 77: 31\u201336.","journal-title":"Clin Exp Immunol"},{"key":"BF3302016_CR99","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1006\/clin.1997.4390","volume":"84","author":"RW McMurray","year":"1997","unstructured":"McMurray RW, Hoffman RW, Nelson W, Walker SE . Cytokine mRNA expression in the B\/W mouse model of systemic lupus erythematosus \u2013 analyses of strain, gender, and age effects. Clin Immunol Immunopathol 1997; 84: 260\u2013268.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF3302016_CR100","first-page":"927","volume":"144","author":"B Ryffel","year":"1994","unstructured":"Ryffel B et al. Interleukin-6 exacerbates glomerulonephritis in (NZB \u00d7 NZW)F1 mice. Am J Pathol 1994; 144: 927\u2013937.","journal-title":"Am J Pathol"},{"key":"BF3302016_CR101","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1172\/JCI117373","volume":"94","author":"BK Finck","year":"1994","unstructured":"Finck BK, Chan B, Wofsy D . Interleukin 6 promotes murine lupus in NZB\/NZW F1 mice. J Clin Invest 1994; 94: 585\u2013591.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR102","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/08916939508993357","volume":"21","author":"A Shirai","year":"1995","unstructured":"Shirai A, Conover J, Klinman DM . Increased activation and altered ratio of interferon-gamma: interleukin-4 secreting cells in MRL-lpr\/lpr mice. Autoimmunity 1995; 21: 107\u2013116.","journal-title":"Autoimmunity"},{"key":"BF3302016_CR103","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000236484","volume":"101","author":"M Dueymes","year":"1993","unstructured":"Dueymes M et al. Relationship of interleukin-4 to isotypic distribution of anti-double-stranded DNA antibodies in systemic lupus erythematosus. Int Arch Allergy Immunol 1993; 101: 408\u2013415.","journal-title":"Int Arch Allergy Immunol"},{"key":"BF3302016_CR104","first-page":"267","volume":"47","author":"Y Richaud-Patin","year":"1995","unstructured":"Richaud-Patin Y, Alcocer-Varela J, Llorente L . High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev Invest Clin 1995; 47: 267\u2013272.","journal-title":"Rev Invest Clin"},{"key":"BF3302016_CR105","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1006\/clim.2001.5182","volume":"102","author":"V Rus","year":"2002","unstructured":"Rus V et al. Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol 2002; 102: 283\u2013290.","journal-title":"Clin Immunol"},{"key":"BF3302016_CR106","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1084\/jem.185.1.65","volume":"185","author":"ML Santiago","year":"1997","unstructured":"Santiago ML et al. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 1997; 185: 65\u201370.","journal-title":"J Exp Med"},{"key":"BF3302016_CR107","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/art.1780390305","volume":"39","author":"E Hagiwara","year":"1996","unstructured":"Hagiwara E, Gourley MF, Lee S, Klinman DK . Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum 1996; 39: 379\u2013385.","journal-title":"Arthritis Rheum"},{"key":"BF3302016_CR108","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1084\/jem.179.1.305","volume":"179","author":"H Ishida","year":"1994","unstructured":"Ishida H et al. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB\/W F1 mice. J Exp Med 1994; 179: 305\u2013310.","journal-title":"J Exp Med"},{"key":"BF3302016_CR109","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1172\/JCI119806","volume":"100","author":"L Georgescu","year":"1997","unstructured":"Georgescu L, Vakkalanka RK, Elkon KB, Crow MK . Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest 1997; 100: 2622\u20132633.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR110","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1046\/j.1365-3083.1997.d01-140.x","volume":"46","author":"AE Mongan","year":"1997","unstructured":"Mongan AE, Ramdahin S, Warrington RJ . Interleukin-10 response abnormalities in systemic lupus erythematosus. Scand J Immunol 1997; 46: 406\u2013412.","journal-title":"Scand J Immunol"},{"key":"BF3302016_CR111","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF02238963","volume":"16","author":"JK Lacki","year":"1997","unstructured":"Lacki JK, Samborski W, Mackiewicz SH . Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins. Clin Rheumatol 1997; 16: 275\u2013278.","journal-title":"Clin Rheumatol"},{"key":"BF3302016_CR112","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1073\/pnas.87.3.1233","volume":"87","author":"CO Jacob","year":"1990","unstructured":"Jacob CO et al. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87: 1233\u20131237.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302016_CR113","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2249.1991.tb05736.x","volume":"85","author":"K Mitamura","year":"1991","unstructured":"Mitamura K et al. Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1991; 85: 386\u2013391.","journal-title":"Clin Exp Immunol"},{"key":"BF3302016_CR114","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/08916939908994055","volume":"31","author":"BM Jones","year":"1999","unstructured":"Jones BM, Liu T, Wong RW . Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity. Autoimmunity 1999; 31: 117\u2013124.","journal-title":"Autoimmunity"},{"key":"BF3302016_CR115","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1084\/jem.185.9.1573","volume":"185","author":"AP Cope","year":"1997","unstructured":"Cope AP et al. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 1997; 185: 1573\u20131584.","journal-title":"J Exp Med"},{"key":"BF3302016_CR116","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.4049\/jimmunol.141.9.3043","volume":"141","author":"Y Tanaka","year":"1988","unstructured":"Tanaka Y et al. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol 1988; 141: 3043\u20133049.","journal-title":"J Immunol"},{"key":"BF3302016_CR117","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/BF02206840","volume":"6","author":"S Sierakowski","year":"1987","unstructured":"Sierakowski S, Kucharz EJ, Lightfoot Jr RW, Goodwin JS . Interleukin-1-production by monocytes from patients with systemic lupus erythematosus. Clin Rheumatol 1987; 6: 403\u2013407.","journal-title":"Clin Rheumatol"},{"key":"BF3302016_CR118","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.4049\/jimmunol.143.11.3470","volume":"143","author":"DC Brennan","year":"1989","unstructured":"Brennan DC, Yui MA, Wuthrich RP, Kelley VE . Tumor necrosis factor and IL-1 in New Zealand Black\/White mice. Enhanced gene expression and acceleration of renal injury. J Immunol 1989; 143: 3470\u20133475.","journal-title":"J Immunol"},{"key":"BF3302016_CR119","doi-asserted-by":"publisher","first-page":"C117","DOI":"10.1007\/BF01972740","volume":"39","author":"HU Schorlemmer","year":"1993","unstructured":"Schorlemmer HU, Kanzy EJ, Langner KD, Kurrle R . Immunoregulation of SLE-like disease by the IL-1 receptor: disease modifying activity on BDF1 hybrid mice and MRL autoimmune mice. Agents Actions 1993; 39: C117\u2013C120.","journal-title":"Agents Actions"},{"key":"BF3302016_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI115821","volume":"90","author":"WA Border","year":"1992","unstructured":"Border WA, Ruoslahti E . Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1\u20137.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR121","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.180.5.1693","volume":"180","author":"JH Lowrance","year":"1994","unstructured":"Lowrance JH et al. Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL\/lpr mice. J Exp Med 1994; 180: 1693\u20131703.","journal-title":"J Exp Med"},{"key":"BF3302016_CR122","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1517\/14712598.1.3.359","volume":"1","author":"GJ Prud'homme","year":"2001","unstructured":"Prud'homme GJ, Lawson BR, Theofilopoulos AN . Anticytokine gene therapy of autoimmune diseases. Expert Opin Biol Ther 2001; 1: 359\u2013373.","journal-title":"Expert Opin Biol Ther"},{"key":"BF3302016_CR123","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1155\/EDR.2001.3","volume":"2","author":"WL Suarez-Pinzon","year":"2001","unstructured":"Suarez-Pinzon WL, Rabinovitch A . Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits. Int J Exp Diabetes Res 2001; 2: 3\u201317.","journal-title":"Int J Exp Diabetes Res"},{"key":"BF3302016_CR124","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1006\/jaut.1999.0339","volume":"14","author":"GJ Prud'homme","year":"2000","unstructured":"Prud'homme GJ, Piccirillo CA . The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 2000; 14: 23\u201342.","journal-title":"J Autoimmun"},{"key":"BF3302016_CR125","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.4049\/jimmunol.146.9.3012","volume":"146","author":"MK Racke","year":"1991","unstructured":"Racke MK et al. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol 1991; 146: 3012\u20133017.","journal-title":"J Immunol"},{"key":"BF3302016_CR126","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1073\/pnas.88.7.2918","volume":"88","author":"AP Kuruvilla","year":"1991","unstructured":"Kuruvilla AP et al. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 1991; 88: 2918\u20132921.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302016_CR127","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1073\/pnas.90.10.4523","volume":"90","author":"E Raz","year":"1993","unstructured":"Raz E et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci USA 1993; 90: 4523\u20134527.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302016_CR128","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.161.8.3950","volume":"161","author":"CA Piccirillo","year":"1998","unstructured":"Piccirillo CA, Chang Y, Prud'homme GJ . TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. J Immunol 1998; 161: 3950\u20133956.","journal-title":"J Immunol"},{"key":"BF3302016_CR129","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/096120339500400409","volume":"4","author":"E Raz","year":"1995","unstructured":"Raz E et al. Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 1995; 4: 286\u2013292.","journal-title":"Lupus"},{"key":"BF3302016_CR130","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1749-6632.1997.tb52114.x","volume":"815","author":"ML Huggins","year":"1997","unstructured":"Huggins ML et al. Modulation of the autoimmune response in lupus mice by oral administration of attenuated Salmonella typhimurium expressing the IL-2 and TGF-beta genes. Ann NY Acad Sci 1997; 815: 499\u2013502.","journal-title":"Ann NY Acad Sci"},{"key":"BF3302016_CR131","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1191\/096120399678847308","volume":"8","author":"ML Huggins","year":"1999","unstructured":"Huggins ML et al. Modulation of autoimmune disease in the MRL-lpr\/lpr mouse by IL-2 and TGF-beta1 gene therapy using attenuated Salmonella typhimurium as gene carrier. Lupus 1999; 8: 29\u201338.","journal-title":"Lupus"},{"key":"BF3302016_CR132","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1006\/cyto.1999.0662","volume":"12","author":"E Hagiwara","year":"2000","unstructured":"Hagiwara E et al. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL\/MP-lpr\/lpr mice. Cytokine 2000; 12: 1035\u20131041.","journal-title":"Cytokine"},{"key":"BF3302016_CR133","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.19.1.225","volume":"19","author":"B Salomon","year":"2001","unstructured":"Salomon B, Bluestone JA . Complexities of CD28\/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225\u2013252.","journal-title":"Annu Rev Immunol"},{"key":"BF3302016_CR134","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1517\/13543784.9.9.2147","volume":"9","author":"N Najafian","year":"2000","unstructured":"Najafian N, Sayegh MH . CTLA4-Ig: a novel immunosuppressive agent. Expert Opin Invest Drugs 2000; 9: 2147\u20132157.","journal-title":"Expert Opin Invest Drugs"},{"key":"BF3302016_CR135","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0024-3205(99)00664-5","volume":"66","author":"M Takiguchi","year":"2000","unstructured":"Takiguchi M et al. CTLA4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL\/lpr mice. Life Sci 2000; 66: 991\u20131001.","journal-title":"Life Sci"},{"key":"BF3302016_CR136","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.gt.3300879","volume":"6","author":"GJ Prud'homme","year":"1999","unstructured":"Prud'homme GJ, Chang Y . Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor\/IgG1 fusion protein. Gene Therapy 1999; 6: 771\u2013777.","journal-title":"Gene Therapy"},{"key":"BF3302016_CR137","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/(SICI)1521-2254(199911\/12)1:6<415::AID-JGM66>3.0.CO;2-B","volume":"1","author":"Y Chang","year":"1999","unstructured":"Chang Y, Prud'homme GJ . Intramuscular administration of expression plasmids encoding interferon-gamma receptor\/IgG1 or IL-4\/IgG1 chimeric proteins protects from autoimmunity. J Gene Med 1999; 1: 415\u2013423.","journal-title":"J Gene Med"},{"key":"BF3302016_CR138","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/1521-2254(200007\/08)2:4<222::AID-JGM117>3.0.CO;2-P","volume":"2","author":"GJ Prud'homme","year":"2000","unstructured":"Prud'homme GJ . Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors. J Gene Med 2000; 2: 222\u2013232.","journal-title":"J Gene Med"},{"key":"BF3302016_CR139","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1089\/hum.1996.7.10-1205","volume":"7","author":"J Hartikka","year":"1996","unstructured":"Hartikka J et al. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 1996; 7: 1205\u20131217.","journal-title":"Hum Gene Ther"},{"key":"BF3302016_CR140","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/ar290","volume":"3","author":"AN Theofilopoulos","year":"2001","unstructured":"Theofilopoulos AN, Koundouris S, Kono DH, Lawson BR . The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1\/Th2 paradigm in autoimmunity. Arthritis Res 2001;3: 136\u2013141.","journal-title":"Arthritis Res"},{"key":"BF3302016_CR141","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1172\/JCI10167","volume":"106","author":"BR Lawson","year":"2000","unstructured":"Lawson BR et al. Treatment of murine lupus with cDNA encoding IFN-gammaR\/Fc. J Clin Invest 2000; 106: 207\u2013215.","journal-title":"J Clin Invest"},{"key":"BF3302016_CR142","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.96.8.4262","volume":"96","author":"LM Mir","year":"1999","unstructured":"Mir LM et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96: 4262\u20134267.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302016_CR143","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","volume":"20","author":"AM Krieg","year":"2002","unstructured":"Krieg AM . CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20: 709\u2013760.","journal-title":"Annu Rev Immunol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302016","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:25:11Z","timestamp":1684862711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":143,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,5,1]]}},"alternative-id":["BF3302016"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302016","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,1]]},"assertion":[{"value":"6 May 2003","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}